U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 296

Tests names and labsConditionsGenes, analytes, and microbesMethods

Colorectal Cancer Panel

QDx Pathology Services, Inc.
United States
619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome

QDx Pathology Services, Inc.
United States
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

QDx Pathology Services, Inc.
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome

Clariti Diagnostics Laboratories LLC
United States
55
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Panel

Clariti Diagnostics Laboratories LLC
United States
619
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

Clariti Diagnostics Laboratories LLC
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Guardant Shield LDT

Guardant Health
United States
11
  • P Protein analysis
  • M Methylation analysis
  • E Sequence analysis of select exons

Tumor, Microsatellite Instability

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • I Microsatellite instability testing (MSI)

KRAS Mutation Analysis

PathGroup
United States
131
  • T Targeted variant analysis

Otogenetics Hereditary Cancers

Otogenetics
United States
3639
  • E Sequence analysis of select exons

EP300 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MLH3 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Bone Marrow Failure / Anemia Panel

Centogene US, LLC - The Rare Disease Company
United States
212212
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoDysmorph Panel

Centogene US, LLC - The Rare Disease Company
United States
740728
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Connective Tissue and Related Disorder Panel

Centogene US, LLC - The Rare Disease Company
United States
7576
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neuromuscular Panel

Centogene US, LLC - The Rare Disease Company
United States
325316
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pancreatitis Panel

Centogene US, LLC - The Rare Disease Company
United States
2729
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pulmonary Panel

Centogene US, LLC - The Rare Disease Company
United States
99101
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

AKT1 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHEK2 - MLPA

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis

Results: 1 to 20 of 296

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.